Checkmarx One and ImmuniWeb are security solutions competing in the application security category. ImmuniWeb has a slight advantage due to its robust features, while Checkmarx One is noted for favorable pricing and support feedback.
Features: Checkmarx One offers comprehensive security testing, integration capabilities, and in-depth code analysis. ImmuniWeb features AI-driven security testing, user-friendly vulnerability processes, and advanced threat identification capabilities.
Room for Improvement: Checkmarx One could improve report customization, integration with development tools, and expand support for newer technologies. ImmuniWeb needs faster processing speed, broader language support, and better onboarding resources.
Ease of Deployment and Customer Service: Checkmarx One provides seamless deployment and responsive customer service with extensive support. ImmuniWeb focuses on quick implementation, though some users note a learning curve that could improve with better onboarding.
Pricing and ROI: Checkmarx One offers flexible pricing models with a clear path to ROI, appealing to budget-conscious users. ImmuniWeb is seen as premium-priced but provides significant returns through advanced capabilities, making it a justified investment for many.
Checkmarx One is an enterprise cloud-native application security platform focused on providing cross-tool, correlated results to help AppSec and developer teams prioritize where to focus time and resources.
Checkmarx One offers comprehensive application scanning across the SDLC:
Checkmarx One provides everything you need to secure application development from the first line of code through deployment and runtime in the cloud. With an ever-evolving set of AppSec engines, correlation and prioritization features, and AI capabilities, Checkmarx One helps consolidate expanding lists of AppSec tools and make better sense of results. Its capabilities are designed to provide an improved developer experience to build trust with development teams and ensure the success of your AppSec program investment.
ImmuniWeb is a global application security company operating in over 50 countries, headquartered in Geneva, Switzerland. Most of ImmuniWeb's customers come from regulated industries, such as banking, healthcare, and e-commerce.
ImmuniWeb® AI Platform leverages award-winning AI and Machine Learning technology for acceleration and intelligent automation of Attack Surface Management and Dark Web Monitoring. The data is later leveraged for threat-aware and risk-based Application Penetration Testing for web, mobile, and API security testing. ImmuniWeb is the only company that offers a contractual zero false-positives SLA with a money-back guarantee. ImmuniWeb’s AI technology is a recipient of numerous awards and recognitions, including Gartner Cool Vendor, IDC Innovator, and the winner of “SC Award Europe” in the “Best Usage of Machine Learning and AI” category.
ImmuniWeb® Community Edition runs over 100,000 daily tests, being one of the largest application security communities. ImmuniWeb SA is an ISO 27001 certified and CREST-accredited company.
We monitor all Static Application Security Testing (SAST) reviews to prevent fraudulent reviews and keep review quality high. We do not post reviews by company employees or direct competitors. We validate each review for authenticity via cross-reference with LinkedIn, and personal follow-up with the reviewer when necessary.